|
1
|
Li X, Du N, Zhang Q, Li J, Chen X, Liu X,
Hu Y, Qin W, Shen N, Xu C, et al: MicroRNA-30d regulates
cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic
cardiomyopathy. Cell Death Dis. 5:e14792014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parizadeh SM, Jafarzadeh-Esfehani R,
Ghandehari M, Hasanzadeh M, Parizadeh SMR, Hassanian SM,
Rezaei-Kalat A, Aghabozorgi AS, Rahimi-Kakhki R, Zargaran B, et al:
Circulating and tissue microRNAs as biomarkers for ovarian cancer
prognosis. Curr Drug Targets. 20:1447–1460. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mülayim B, Gürakan H, Dagli V, Mülayim S,
Aydin O and Akkaya H: Unaware of a giant serous cyst adenoma: A
case report. Arch Gynecol Obstet. 273:381–383. 2006. View Article : Google Scholar
|
|
4
|
Menke K, Schwermer M, Falke K, Felenda J,
Beckmann C, Stintzing F, Voigt A, Schramm A and Zuzak TJ: Taraxacum
officinale extract induces antitumorigenic effects in ovarian
carcinoma cell lines. Eur J Gynaecol Oncol. 40:106–112. 2019.
|
|
5
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe Estimates
for 40 countries in 2012. Eur J Cancer. 49:1374–1403. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lim W and Song G: Discovery of prognostic
factors for diagnosis and treatment of epithelial-derived ovarian
cancer from laying hens. J Cancer Prev. 18:209–220. 2013.
View Article : Google Scholar
|
|
7
|
Lheureux S, Gourley C, Vergote I and Oza
AM: Epithelial ovarian cancer. Lancet. 393:1240–1253. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Motohara T and Katabuchi H: Ovarian cancer
stemness: Biological and clinical implications for metastasis and
chemotherapy resistance. Cancers (Basel). 11:9072019. View Article : Google Scholar
|
|
9
|
Kagiya T: MicroRNAs: Potential biomarkers
and therapeutic targets for alveolar bone loss in periodontal
disease. Int J Mol Sci. 17:13172016. View Article : Google Scholar :
|
|
10
|
Piletič K and Kunej T: MicroRNA epigenetic
signatures in human disease. Arch Toxicol. 90:2405–2419. 2016.
View Article : Google Scholar
|
|
11
|
Varamo C, Occelli M, Vivenza D, Merlano M
and Lo Nigro C: MicroRNAs role as potential biomarkers and key
regulators in melanoma. Genes Chromosomes Cancer. 56:3–10. 2017.
View Article : Google Scholar
|
|
12
|
Chen J: miRNA-195 suppresses cell
proliferation of ovarian cancer cell by regulating VEGFR2 and AKT
signaling pathways. Mol Med Rep. 18:1666–1673. 2018.PubMed/NCBI
|
|
13
|
Pang H, Xu X, Dai L, Wang K and Yao X:
MicroRNA-195 is associated with regulating the pathophysiologic
process of human laryngeal squamous cell carcinoma. Mol Med Rep.
17:5283–5291. 2018.PubMed/NCBI
|
|
14
|
Fu HL, Wu DP, Wang XF, Wang JG, Jiao F,
Song LL, Xie H, Wen XY, Shan HS, Du YX and Zhao YP: Altered miRNA
expression is associated with differentiation, invasion, and
metastasis of esophageal squamous cell carcinoma (ESCC) in patients
from Huaian, China. Cell Biochem Biophys. 67:657–668. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun N, Ye L, Chang T and Li X and Li X:
microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal
squamous cell carcinoma. Int J Clin Exp Pathol. 7:6871–6879.
2014.PubMed/NCBI
|
|
16
|
Yin Y, Hong S, Yu S, Huang Y, Chen S, Liu
Y, Zhang Q, Li Y and Xiao H: MiR-195 inhibits tumor growth and
metastasis in papillary thyroid carcinoma cell lines by targeting
CCND1 and FGF2. Int J Endocrinol. 2017:61804252017. View Article : Google Scholar :
|
|
17
|
Pi J, Liu J, Zhuang T, Zhang L, Sun H,
Chen X, Zhao Q, Kuang Y, Peng S, Zhou X, et al: Elevated Expression
of miR302-367 in endothelial cells inhibits developmental
angiogenesis via CDC42/CCND1 mediated signaling pathways.
Theranostics. 8:1511–1526. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Dong N, Xu B, Benya SR and Tang X:
MiRNA-26b inhibits the proliferation, migration, and
epithelial-mesenchymal transition of lens epithelial cells. Mol
Cell Biochem. 396:229–238. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dong M, Xie Y and Xu Y: miR-7-5p regulates
the proliferation and migration of colorectal cancer cells by
negatively regulating the expression of Krüppel-like factor 4.
Oncol Lett. 17:3241–3246. 2019.PubMed/NCBI
|
|
21
|
Fan X, Liu M, Tang H, Leng D, Hu S, Lu R,
Wan W and Yuan S: MicroRNA-7 exerts antiangiogenic effect on
colorectal cancer via ERK signaling. J Surg Res. 240:48–59. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cui J, Li W, Liu G, Chen X, Gao X, Lu H
and Lin D: A novel circular RNA, hsa_circ_0043278, acts as a
potential biomarker and promotes non-small cell lung cancer cell
proliferation and migration by regulating miR-520f. Artif Cells
Nanomed Biotechnol. 47:810–821. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Galoian KA, Guettouche T, Issac B, Qureshi
A and Temple HT: Regulation of onco and tumor suppressor MiRNAs by
mTORC1 inhibitor PRP-1 in human chondrosarcoma. Tumour Biol.
35:2335–2341. 2014. View Article : Google Scholar
|
|
24
|
Wang H: Predicting cancer-related MiRNAs
using expression profiles in tumor tissue. Curr Pharm Biotechnol.
15:438–444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thomas J, Ohtsuka M, Pichler M and Ling H:
MicroRNAs: Clinical relevance in colorectal cancer. Int J Mol Sci.
16:28063–28076. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xie X, Xu X, Sun C and Yu Z: Long
intergenic noncoding RNA SNHG16 interacts with miR-195 to promote
proliferation, invasion and tumorigenesis in hepatocellular
carcinoma. Exp Cell Res. 383:1115012019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen LP, Zhang NN, Ren XQ, He J and Li Y:
miR-103/miR-195/miR-15b regulate SALL4 and inhibit proliferation
and migration in Glioma. Molecules. 23:29382018. View Article : Google Scholar :
|
|
28
|
Li B and Wang S and Wang S: MiR-195
suppresses colon cancer proliferation and metastasis by targeting
WNT3A. Mol Genet Genomics. 293:1245–1253. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maroof H, Irani S, Arianna A, Vider J,
Gopalan V and Lam AK: Interactions of vascular endothelial growth
factor and p53 with miR-195 in thyroid carcinoma: Possible
therapeutic targets in aggressive thyroid cancers. Curr Cancer Drug
Targets. 19:561–570. 2019. View Article : Google Scholar
|
|
30
|
Humphreys KJ, McKinnon RA and Michael MZ:
miR-18a inhibits CDC42 and plays a tumour suppressor role in
colorectal cancer cells. PLoS One. 9:e1122882014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Satterfield L, Shuck R, Kurenbekova L,
Allen-Rhoades W, Edwards D, Huang S, Rajapakshe K, Coarfa C,
Donehower LA and Yustein JT: miR-130b directly targets ARHGAP1 to
drive activation of a metastatic CDC42-PAK1-AP1 positive feedback
loop in Ewing sarcoma. Int J Cancer. 141:2062–2075. 2017.
View Article : Google Scholar : PubMed/NCBI
|
